These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 15932833)

  • 1. The effect of Medicare health care systems on women with breast and cervical cancer.
    Kirsner RS; Ma F; Fleming L; Trapido E; Duncan R; Federman DG; Wilkinson JD
    Obstet Gynecol; 2005 Jun; 105(6):1381-8. PubMed ID: 15932833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of medicare health care delivery systems on survival for patients with breast and colorectal cancer.
    Kirsner RS; Ma F; Fleming L; Federman DG; Trapido E; Duncan R; Wilkinson JD
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):769-73. PubMed ID: 16614122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of Medicare health care delivery systems with stage at diagnosis and survival for patients with melanoma.
    Kirsner RS; Wilkinson JD; Ma F; Pacheco H; Federman DG
    Arch Dermatol; 2005 Jun; 141(6):753-7. PubMed ID: 15967922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of a change in Medicare reimbursement policy and HEDIS measures on stage at diagnosis among Medicare HMO and fee-for-service female breast cancer patients.
    Habermann EB; Virnig BA; Riley GF; Baxter NN
    Med Care; 2007 Aug; 45(8):761-6. PubMed ID: 17667310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managed care enrollment and chronically disabled women with breast cancer.
    Habermann EB; Virnig BA; Durham SB; Baxter NN
    Am J Manag Care; 2008 Aug; 14(8):514-20. PubMed ID: 18690767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector?
    Keating NL; Landrum MB; Meara E; Ganz PA; Guadagnoli E
    J Natl Cancer Inst; 2005 Feb; 97(4):257-64. PubMed ID: 15713960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of functional outcomes after hip fracture in group/staff HMOs and fee-for-service systems.
    Coleman EA; Kramer AM; Kowalsky JC; Eckhoff D; Lin M; Hester EJ; Morgenstern N; Steiner JF
    Eff Clin Pract; 2000; 3(5):229-39. PubMed ID: 11185328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
    Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
    Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients.
    Potosky AL; Merrill RM; Riley GF; Taplin SH; Barlow W; Fireman BH; Lubitz JD
    Health Serv Res; 1999 Jun; 34(2):525-46. PubMed ID: 10357289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year changes in health and functional status among elderly Medicare beneficiaries in HMOs and fee-for-service.
    Riley G
    Health Serv Res; 2000 Dec; 35(5 Pt 3):44-59. PubMed ID: 16148951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Medicare-HMO revolving door--the healthy go in and the sick go out.
    Morgan RO; Virnig BA; DeVito CA; Persily NA
    N Engl J Med; 1997 Jul; 337(3):169-75. PubMed ID: 9219704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical outcomes of care for breast cancer among health maintenance organization and fee-for-service patients.
    Vernon SW; Heckel V; Jackson GL
    Clin Cancer Res; 1995 Feb; 1(2):179-84. PubMed ID: 9815971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of mortality and intermediate outcomes between medicare dialysis patients in HMO and fee for service.
    Eggers PW; Frankenfield DL; Greer JW; McClellan W; Owen WF; Rocco MV
    Am J Kidney Dis; 2002 Apr; 39(4):796-804. PubMed ID: 11920346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inpatient utilization by dual Medicare-Medicaid eligibles in Medicare risk HMOs and fee for service, California, 1991-1996.
    Sloss EM; Dhanani N; O'Leary JF; Lopez MS; Melnick G
    Manag Care Interface; 2004 Dec; 17(12):30-4, 41. PubMed ID: 15656377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a decline in Colorado Medicaid managed care enrollment on access and quality of preventive primary care services.
    Berman S; Armon C; Todd J
    Pediatrics; 2005 Dec; 116(6):1474-9. PubMed ID: 16322173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative management of colon cancer under Medicare risk programs.
    Retchin SM; Penberthy L; Desch C; Brown R; Jerome-D'Emilia B; Clement D
    Arch Intern Med; 1997 Sep; 157(16):1878-84. PubMed ID: 9290548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stage comparison between dual Medicare-Medicaid eligibles using Medicaid as a supplemental health insurance program and low-income nonduals.
    Koroukian SM; Bakaki PM; Beaird H; Earle CC; Cooper GS
    J Public Health Manag Pract; 2011; 17(6):479-91. PubMed ID: 21964357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of ineffective or unsafe medications among members of a Medicare HMO compared to individuals in a Medicare fee-for-service program.
    Futterman R; Fillit H; Roglieri JL
    Am J Manag Care; 1997 Apr; 3(4):569-75. PubMed ID: 10169525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of Medicare fee-for-service and a group-model HMO in the inpatient management and long-term survival of elderly individuals with syncope.
    Getchell WS; Larsen GC; Morris CD; McAnulty JH
    Am J Manag Care; 2000 Oct; 6(10):1089-98. PubMed ID: 11184665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of HMOs on fee-for-service health care expenditures: evidence from Medicare revisited.
    Batata A
    J Health Econ; 2004 Sep; 23(5):951-63. PubMed ID: 15353188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.